Fulcrum Therapeutics, Inc. — All Filings
468 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
POS EX
POSASR
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-3MEF
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-001344 | Mar 26, 2026 | — |
| 8-K | 8-K | 0001193125-26-065190 | Feb 24, 2026 | — |
| S-8 | S-8 | 0001193125-26-065206 | Feb 24, 2026 | — |
| 10-K | 10-K | 0001193125-26-065197 | Feb 24, 2026 | Dec 31, 2025 |
| SCHEDULE 13G/A | — | 0001346824-26-000043 | Feb 17, 2026 | — |
| 4 | 4 | 0001193125-26-037572 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | 4 | 0001193125-26-037576 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | 4 | 0001193125-26-037574 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | 4 | 0001193125-26-037573 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | 4 | 0001193125-26-037575 | Feb 4, 2026 | Feb 2, 2026 |
| 4/A | 4/A | 0001193125-26-037606 | Feb 4, 2026 | Jan 2, 2026 |
| 8-K | 8-K | 0001193125-26-009845 | Jan 12, 2026 | — |
| 4 | 4 | 0001193125-26-004572 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-25-322740 | Dec 17, 2025 | Dec 15, 2025 |
| 144 | — | 0001950047-25-010350 | Dec 15, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-314724 | Dec 11, 2025 | — |
| 8-K | 8-K | 0001193125-25-314728 | Dec 11, 2025 | Dec 10, 2025 |
| 4 | — | 0001231919-25-000596 | Dec 10, 2025 | Dec 8, 2025 |
| SCHEDULE 13G/A | — | 0001346824-25-000068 | Dec 10, 2025 | — |
| FWP | FWP | 0001193125-25-313415 | Dec 10, 2025 | — |
| 144 | — | 0001178937-25-000086 | Dec 8, 2025 | — |
| 8-K | 8-K | 0001193125-25-310509 | Dec 8, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-311359 | Dec 8, 2025 | — |
| 4 | 4 | 0001193125-25-291392 | Nov 21, 2025 | Nov 19, 2025 |
| 144 | — | 0001950047-25-009089 | Nov 19, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-004883 | Nov 13, 2025 | — |
| 8-K | 8-K | 0001193125-25-254619 | Oct 29, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-254633 | Oct 29, 2025 | Sep 30, 2025 |
| SCHEDULE 13G/A | — | 0002012383-25-002864 | Oct 17, 2025 | — |
| 8-K | 8-K | 0001193125-25-190746 | Aug 28, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-003497 | Aug 12, 2025 | — |
| 8-K | 8-K | 0000950170-25-099404 | Jul 29, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-099407 | Jul 29, 2025 | Jun 30, 2025 |
| 4 | 4 | 0000950170-25-091577 | Jun 30, 2025 | Jun 26, 2025 |
| 4 | 4 | 0000950170-25-091583 | Jun 30, 2025 | Jun 26, 2025 |
| 4 | 4 | 0000950170-25-091584 | Jun 30, 2025 | Jun 26, 2025 |
| 4 | 4 | 0000950170-25-091578 | Jun 30, 2025 | Jun 26, 2025 |
| 4 | 4 | 0000950170-25-091579 | Jun 30, 2025 | Jun 26, 2025 |
| 4 | 4 | 0000950170-25-091580 | Jun 30, 2025 | Jun 26, 2025 |
| 4 | 4 | 0000950170-25-091585 | Jun 30, 2025 | Jun 26, 2025 |
| 4 | 4 | 0000950170-25-091582 | Jun 30, 2025 | Jun 26, 2025 |
| 8-K | 8-K | 0001193125-25-151276 | Jun 27, 2025 | Jun 26, 2025 |
| 4 | 4 | 0000950170-25-068038 | May 9, 2025 | May 8, 2025 |
| DEFR14A | DEFR14A | 0000950170-25-065795 | May 7, 2025 | — |
| SCHEDULE 13G/A | — | 0000919574-25-002740 | May 2, 2025 | — |
| 8-K | 8-K | 0000950170-25-061439 | May 1, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-061442 | May 1, 2025 | Mar 31, 2025 |
| DEF 14A | DEF 14A | 0000950170-25-061000 | Apr 30, 2025 | Apr 25, 2025 |
| DEFA14A | DEFA14A | 0000950170-25-061013 | Apr 30, 2025 | — |
| ARS | ARS | 0000950170-25-061020 | Apr 30, 2025 | Dec 31, 2024 |